Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma
NCT00085774 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2021-11-24
Summary
This study was designed to examine the effectiveness of two bronchodilator inhalers in patients who have exercise-induced asthma.
Conditions
- Exercise-induced Bronchospasm
Interventions
- DRUG
-
albuterol aerosol by HFA MDI
albuterol HFA MDI 160 mcg
- DRUG
-
albuterol aerosol by HFA BOI
albuterol HFA BOI 160 mcg
- DRUG
-
placebo aerosol by HFA
placebo HFA
Sponsors & Collaborators
-
Teva Branded Pharmaceutical Products R&D, Inc.
lead INDUSTRY
Principal Investigators
-
David S Pearlman, MD · Colorado Allergy and Asthma Centers, PC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-06-30
- Primary Completion
- 2004-09-30
- Completion
- 2004-09-30
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma
NCT04234464 ·Status: COMPLETED ·Phase: PHASE3
-
Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction
NCT00634829 ·Status: TERMINATED ·Phase: PHASE3
-
Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol
NCT00685425 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers
NCT02777125 ·Status: COMPLETED ·Phase: NA
-
Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma
NCT00530062 ·Status: COMPLETED ·Phase: PHASE4
-
A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
NCT02126839 ·Status: COMPLETED ·Phase: PHASE3
-
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
NCT00127166 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
NCT01844401 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
NCT00112411 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics
NCT00308685 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
NCT02584257 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
NCT01899144 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital
NCT00623688 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma
NCT00684866 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive
NCT06433908 ·Status: COMPLETED ·Phase: PHASE1
-
A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
NCT01056159 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma
NCT02182505 ·Status: COMPLETED ·Phase: PHASE3
-
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
NCT00096616 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB
NCT00268723 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise
NCT01435902 ·Status: WITHDRAWN ·Phase: PHASE3
-
Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT02447575 ·Status: COMPLETED ·Phase: NA
-
A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)
NCT01258803 ·Status: COMPLETED ·Phase: PHASE2
-
4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma
NCT00634517 ·Status: TERMINATED ·Phase: PHASE3
-
Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions
NCT04803734 ·Status: COMPLETED ·Phase: NA
-
Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients
NCT00635505 ·Status: TERMINATED ·Phase: PHASE3